Oxford, UK-based Adaptimmune has formed a clinical trial pact with MSD to test a potential new combination therapy for multiple myeloma. Oxford, UK-based Adaptimmune has formed a clinical trial pact ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile